Barchi Leandro Cardoso, Ramos Marcus Fernando Kodama Pertille, Dias André Roncon, Forones Nora Manoukian, Carvalho Marineide Prudêncio de, Castro Osvaldo Antonio Prado, Kassab Paulo, Costa-Júnior Wilson Luiz da, Weston Antônio Carlos, Zilberstein Bruno, Ferraz Álvaro Antônio Bandeira, ZeideCharruf Amir, Brandalise André, Silva André Maciel da, Alves Barlon, Marins Carlos Augusto Martinez, Malheiros Carlos Alberto, Leite Celso Vieira, Bresciani Claudio José Caldas, Szor Daniel, Mucerino Donato Roberto, Wohnrath Durval R, JirjossIlias Elias, Martins Filho Euclides Dias, PinatelLopasso Fabio, Coimbra Felipe José Fernandez, Felippe Fernando E Cruz, Tomasisch Flávio Daniel Saavedra, Takeda Flavio Roberto, Ishak Geraldo, Laporte Gustavo Andreazza, Silva Herbeth José Toledo, Cecconello Ivan, Rodrigues Joaquim José Gama, Grande José Carlos Del, Lourenço Laércio Gomes, Motta Leonardo Milhomem da, Ferraz Leonardo Rocha, Moreira Luis Fernando, Lopes Luis Roberto, Toneto Marcelo Garcia, Mester Marcelo, Rodrigues Marco Antônio Gonçalves, Franciss Maurice Youssef, AdamiAndreollo Nelson, Corletta Oly Campos, Yagi Osmar Kenji, Malafaia Osvaldo, Assumpção Paulo Pimentel, Savassi-Rocha Paulo Roberto, Colleoni Neto Ramiro, Oliveira Rodrigo Jose de, AissarSallun Rubens Antonio, Weschenfelder Rui, Oliveira Saint Clair Vieira de, Abreu Thiago Boechat de, Castria Tiago Biachi de, Ribeiro Junior Ulysses, Barra Williams, Freitas Júnior Wilson Rodrigues de
Hospital das Clinicas HCFMUSP, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil.
Faculty of Medicine São Leopoldo Mandic, Campinas, SP, Brazil.
Arq Bras Cir Dig. 2021 May 14;34(1):e1563. doi: 10.1590/0102-672020210001e1563. eCollection 2021.
: The II Brazilian Consensus on Gastric Cancer of the Brazilian Gastric Cancer Association BGCA (Part 1) was recently published. On this occasion, countless specialists working in the treatment of this disease expressed their opinion in the face of the statements presented.
: To present the BGCA Guidelines (Part 2) regarding indications for surgical treatment, operative techniques, extension of resection and multimodal treatment.
To formulate these guidelines, the authors carried out an extensive and current review regarding each declaration present in the II Consensus, using the Medline/PubMed, Cochrane Library and SciELO databases initially with the following descriptors: gastric cancer, gastrectomy, lymphadenectomy, multimodal treatment. In addition, each statement was classified according to the level of evidence and degree of recommendation.
: Of the 43 statements present in this study, 11 (25,6%) were classified with level of evidence A, 20 (46,5%) B and 12 (27,9%) C. Regarding the degree of recommendation, 18 (41,9%) statements obtained grade of recommendation 1, 14 (32,6%) 2a, 10 (23,3%) 2b e one (2,3%) 3.
: The guidelines complement of the guidelines presented here allows surgeons and oncologists who work to combat gastric cancer to offer the best possible treatment, according to the local conditions available.
巴西胃癌协会（BGCA）第二届巴西胃癌共识（第一部分）最近发表。在此之际，无数从事该疾病治疗的专家对所提出的声明发表了意见。
介绍BGCA关于手术治疗指征、手术技术、切除范围和多模式治疗的指南（第二部分）。
为制定这些指南，作者对第二届共识中的每一项声明进行了广泛且最新的综述，最初使用Medline/PubMed、Cochrane图书馆和SciELO数据库，关键词如下：胃癌、胃切除术、淋巴结清扫术、多模式治疗。此外，每项声明根据证据水平和推荐程度进行分类。
本研究中的43项声明中，11项（25.6%）证据水平为A，20项（46.5%）为B，12项（27.9%）为C。关于推荐程度，18项（41.9%）声明获得1级推荐，14项（32.6%）为2a级，10项（23.3%）为2b级，1项（2.3%）为3级。
此处呈现的指南补充内容使致力于抗击胃癌的外科医生和肿瘤学家能够根据当地现有条件提供尽可能最佳的治疗。
